I totally agree with you for the medium term. My challenge right now is that I don't have access to the DNS records and migrating to a new email service will take days/weeks.
Thanks for the response. Will keep an eye out for that functionality. Fyi, would be willing to pay $100-150/month to give my sales team the ability to run scenarios.
Love the idea! Would gladly pay for it if it supported physical product sales. i.e., ability to add COGS, have a gross margin, etc. Correct me if I am wrong but your current iteration is more geared towards SaaS startups.
Q: What happens if the startup does well after the safe and doesn't need to raise any money and doesn't have a liquidity event? Are the safe investors stuck with a security which does not derive any economic (e.g., dividends) value and they don't have any control?
> For instance, if the BRCA-related risk assessment for breast or ovarian cancer reports a false positive, it could lead a patient to undergo prophylactic surgery, chemoprevention, intensive screening, or other morbidity-inducing actions, while a false negative could result in a failure to recognize an actual risk that may exist.
I cannot imagine someone getting surgery or chemo solely based on a 23andme heads up warning and without consultation with a specialist physician.
As someone working in medical devices, this dramatic language is extremely frustrating.